Attached files

file filename
EX-31.1 - SECTION 302 CEO CFO CERTIFICATE - SYMBOLLON CORPsection302ceocfo_04292010.htm
10-K/A - AMENDED FORM 10-K FOR 12-31-2009 - SYMBOLLON CORPamended10k_12312009.htm
Exhibit 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
AND CHIEF FINANCIAL OFFICER
PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the Annual Report of Symbollon Pharmaceuticals, Inc. (the “Company”) on Form 10-K for the period ended December 31, 2009 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Paul C. Desjourdy, Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
 
1.  
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
2.  
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
 
Date: April 29, 2010             /s/ Paul C. Desjourdy  
Paul C. Desjourdy
Chief Executive Officer and
Chief